{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:30:42Z","timestamp":1789014642413,"version":"build-2803163510"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:00:00Z","timestamp":1461628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100014181","name":"Junta de Extremadura","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014181","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundaci\u00f3n Espa\u00f1ola de Hematolog\u00eda (FEHH)"},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Cancer","award":["RD12\/0036\/0014"],"award-info":[{"award-number":["RD12\/0036\/0014"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The combination of fludarabine, cytarabine, idarubicin, and granulocyte colony\u2010stimulating factor (<jats:styled-content style=\"fixed-case\">FLAG<\/jats:styled-content>\u2010Ida) is widely used in relapsed\/refractory acute myeloid leukaemia (<jats:styled-content style=\"fixed-case\">AML<\/jats:styled-content>). We retrospectively analysed the results of 259 adult <jats:styled-content style=\"fixed-case\">AML<\/jats:styled-content> patients treated as first salvage with <jats:styled-content style=\"fixed-case\">FLAG<\/jats:styled-content>\u2010Ida or <jats:styled-content style=\"fixed-case\">FLAG<\/jats:styled-content>\u2010Ida plus Gentuzumab\u2010Ozogamicin (<jats:styled-content style=\"fixed-case\">FLAGO<\/jats:styled-content>\u2010Ida) of the Programa Espa\u00f1ol de Tratamientos en Hematolog\u00eda (<jats:styled-content style=\"fixed-case\">PETHEMA<\/jats:styled-content>) database, developing a prognostic score system of survival in this setting (<jats:styled-content style=\"fixed-case\">SALFLAGE<\/jats:styled-content> score). Overall, 221 patients received <jats:styled-content style=\"fixed-case\">FLAG<\/jats:styled-content>\u2010Ida and 38 <jats:styled-content style=\"fixed-case\">FLAGO<\/jats:styled-content>\u2010Ida; 92 were older than 60\u00a0years. The complete remission (<jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>)\/<jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content> with incomplete blood count recovery (<jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>i) rate was 51%, with 9% of induction deaths. Three covariates were associated with lower <jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>i: high\u2010risk cytogenetics and <jats:italic>t<\/jats:italic>(8;21) at diagnosis, no previous allogeneic stem cell transplantation (allo\u2010<jats:styled-content style=\"fixed-case\">SCT<\/jats:styled-content>) and relapse\u2010free interval &lt;1\u00a0year. Allo\u2010<jats:styled-content style=\"fixed-case\">SCT<\/jats:styled-content> was performed in second <jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content> in 60 patients (23%). The median overall survival (<jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>) of the entire cohort was 0\u00b77\u00a0years, with 22% <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> at 5\u2010years. Four independent variables were used to construct the score: cytogenetics, <jats:italic><jats:styled-content style=\"fixed-case\">FLT<\/jats:styled-content>3<\/jats:italic>\u2010internal tandem duplication, length of relapse\u2010free interval and previous allo\u2010<jats:styled-content style=\"fixed-case\">SCT<\/jats:styled-content>. Using this stratification system, three groups were defined: favourable (26% of patients), intermediate (29%) and poor\u2010risk (45%), with an expected 5\u2010year <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> of 52%, 26% and 7%, respectively. The <jats:styled-content style=\"fixed-case\">SALFLAGE<\/jats:styled-content> score discriminated a subset of patients with an acceptable long\u2010term outcome using <jats:styled-content style=\"fixed-case\">FLAG<\/jats:styled-content>\u2010Ida\/<jats:styled-content style=\"fixed-case\">FLAGO<\/jats:styled-content>\u2010Ida regimen. The results of this retrospective analysis should be validated in independent external cohorts.<\/jats:p>","DOI":"10.1111\/bjh.14107","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T14:37:26Z","timestamp":1461767846000},"page":"700-710","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A prognostic model for survival after salvage treatment with <scp>FLAG<\/scp>\u2010Ida +\/\u2212 gemtuzumab\u2010ozogamicine in adult patients with refractory\/relapsed acute myeloid leukaemia"],"prefix":"10.1111","volume":"174","author":[{"given":"Juan M.","family":"Bergua","sequence":"first","affiliation":[{"name":"Department of Haematology Hospital San Pedro de Alc\u00e1ntara C\u00e1ceres Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Montesinos","sequence":"additional","affiliation":[{"name":"Department of Haematology University Hospital La Fe Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Martinez\u2010Cuadr\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Haematology University Hospital La Fe Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Fern\u00e1ndez\u2010Abell\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Haematology General Hospital Alicante Alicante Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Serrano","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital Reina Sofia C\u00f3rdoba Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Sayas","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital Doctor Peset Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Prieto\u2010Fernandez","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital San Pedro de Alc\u00e1ntara C\u00e1ceres Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimundo","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Haematology General Hospital Castell\u00f3n Castell\u00f3n Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana J.","family":"Garc\u00eda\u2010Huerta","sequence":"additional","affiliation":[{"name":"Department of Haematology Central Hospital of Asturias Oviedo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Barrios","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital Carlos Haya M\u00e1laga Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Benavente","sequence":"additional","affiliation":[{"name":"Department of Haematology Clinic Hospital Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"P\u00e9rez\u2010Encinas","sequence":"additional","affiliation":[{"name":"Department of Haematology Clinic Hospital Santiago de Compostela Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Simiele","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital Povisa Vigo Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Rodr\u00edguez\u2010Macias","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital Gregorio Mara\u00f1on Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Herrera\u2010Puente","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital Ram\u00f3n y Cajal Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2139-8540","authenticated-orcid":false,"given":"Rebeca","family":"Rodr\u00edguez\u2010Veiga","sequence":"additional","affiliation":[{"name":"Department of Haematology University Hospital La Fe Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda P.","family":"Mart\u00ednez\u2010S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital 12 de Octubre Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Amador\u2010Barciela","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital Montecelo Pontevedra Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosal\u00eda","family":"Riaza\u2010Grau","sequence":"additional","affiliation":[{"name":"Department of Haematology Hospital Severo Ochoa Legan\u00e9s Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Sanz","sequence":"additional","affiliation":[{"name":"Department of Haematology University Hospital La Fe Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the PETHEMA group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.7.1210"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.027"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.036"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.9764"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2011.25"},{"key":"e_1_2_8_7_1","first-page":"6","article-title":"Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate\u2010dose cytarabine with amsidine","volume":"8","author":"Daenen S.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-235358"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401568"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-234492"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.1.116"},{"key":"e_1_2_8_12_1","first-page":"169","article-title":"Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte\u2010colony\u2010stimulating factor during therapy of acute myelogenous leukemia","volume":"1","author":"Gandhi V.","year":"1995","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21187"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.12.4531"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.7.2322"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-254441"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.2.213"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02551.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(99)00087-9"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21351"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.027516"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2009.24.3.498"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.058"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199806)58:2<105::AID-AJH3>3.0.CO;2-W"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-420596"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00277-003-0624-2","article-title":"FLAG\u2010IDA in the treatment of refractory\/relapsed acute myeloid leukemia: single\u2010center experience","volume":"82","author":"Pastore D.","year":"2003","journal-title":"Annals of Hematology"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03150.x"},{"key":"e_1_2_8_28_1","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2014"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.8562"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(02)00003-6"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.012"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.034074"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000181690.21601.09"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.14107","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.14107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T12:58:14Z","timestamp":1696251494000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.14107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1111\/bjh.14107"],"URL":"https:\/\/doi.org\/10.1111\/bjh.14107","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]},"assertion":[{"value":"2015-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}